CSIMarket


Celgene Corp  (CELG)
Other Ticker:  
 


 

Celgene Corp

CELG's Financial Statements and Analysis



Celgene Corp reported in the third quarter of 2019 net earnings per share of $2.32 an increase by 54.67 % year on year from $1.50 and an improvement of 7.41 % from $2.16 realized in II. Quarter (Jun 30 2019).


third quarter of 2019
Earnings Per Share Revenues
$ 2.32 $  4,520 Mill
$+0.82     +54.67 % $+628M     +16.14 %



Celgene's Revenue rose by 16.14 % in third quarter of 2019 (Sep 30 2019) year on year, to $4,520 million and advanced by 2.73 % sequentially.


Celgene is

More on CELG's Income Statement



Celgene's net income of $1,691.000 million in the third quarter of 2019 increased by 56.28 % from net earnings of $1,082.000 million achieved in III. Quarter a year ago.

Sequentially net earnings grew by 7.64 % from net income of $1,571.000 million realized in previous quarter.

More on CELG's Growth

Celgene Inventories
Inventories declined by -11.57 % to $451.00 million from III. Quarter a year ago, sequentially inventories fell by -2.8 %. CELG's Cash flow In the third quarter of 2019 company's net cash flow was $2,390 million, capital expenditures fell by -64631.25%, to $-468 millions compare to same quarter a year ago

More on CELG's Cash flow Statement


Celgene Corp does not pay out common stock dividend.

In trailing twelve-month period Celgene Corp earned $ 11.18 cash per share, on a free-cash flow basis 137.72 % of net earning per share.

Book value grew by 19.80 % sequentially to $16.57 per share, 120.89% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ -16.86 per share from $ -19.19.

Company issued 2.80 million shares or 0.39 % in Sep 30 2019.
Interest Coverage Ratio was 9.73. Debt Coverage Ratio was 0.37.

More on CELG's Dividends

 Market Capitalization (Millions) 78,961
 Shares Outstanding (Millions) 730
 Total Debt (Millions $) 19,787
 Revenue (TTM) (Millions $) 16,982
 Net Income (TTM) (Millions $) 1,834
 Cash Flow (TTM) (Millions $) 7,124
 Capital Exp. (TTM) (Millions $) -695
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 6,012




Celgene Corp does not pay out common stock dividend.

In trailing twelve-month period Celgene Corp had $ 11.18 cash flow per share, on a free-cash flow basis 137.72 % of net earning per share.

Book value grew by 19.80 % sequentially to $16.57 per share, 120.89% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ -16.86 per share from $ -19.19.

Company issued 2.80 million shares or 0.39 % in Sep 30 2019.
Interest Coverage Ratio was 9.73. Debt Coverage Ratio was 0.37.

More on CELG's Balance Sheets

 Market Capitalization (Millions) 78,961
 Shares Outstanding (Millions) 730
 Total Debt (Millions $) 19,787
 Revenue (TTM) (Millions $) 16,982
 Net Income (TTM) (Millions $) 1,834
 Cash Flow (TTM) (Millions $) 7,124
 Capital Exp. (TTM) (Millions $) -695
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 6,012
   



Date modified: -0001-11-30T00:00:00+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com